Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China

Fig. 2

Response rate of intraocular pressure (IOP) reduction ≥ 10%, ≥ 20%, and ≥ 30% in Group A at the last visit. A All; B Baseline IOP ≤ 21 mmHg; C Baseline IOP ≥ 24 mmHg; D response rate of IOP ≤ 16 mmHg, ≤ 18 mmHg, ≤ 20 mmHg in Group A at the last visit

Back to article page